The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Microglia as a source and target of cytokines
Open accessAbstract
Cytokines constitute a significant portion of the immuno‐ and neuromodulatory messengers that can be released by activated microglia. By virtue of potent effects on resident and invading cells, microglial cyto‐ and chemokines regulate innate defense mechanisms, help the initiation and influence the type of immune responses, participate in the recruitment of leukocytes to the CNS, and support attempts of tissue repair and recovery. Microglia can also receive cyto‐ and chemokine signals as part of auto‐ and paracrine communications with astrocytes, neurons, the endothelium, and leukocyte infiltrates. Strong responses and modulatory influences can be demonstrated, adding to the emerging view that microglial behavior is highly dependent on the (cytokine) environment and that reactions to a challenge may vary with the stimulation context. In principle, microglial activation aims at CNS protection. However, failed microglial engagement due to excessive or sustained activation could significantly contribute to acute and chronic neuropathologies. Dysregulation of microglial cytokine production could thereby promote harmful actions of the defense mechanisms, result in direct neurotoxicity, as well as disturb neural cell functions as they are sensitive to cytokine signaling. GLIA 40:140–155, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cellular and molecular mechanisms resulting from injury or infections, underlying the development of proinflammatory cytokines and chemokines in the CNS, are canonically triggered and modulated by astrocytes and microglia (Hanisch, 2002; Murphy et al., 1997)”
From Arbovirus infection increases the risk for the development of neurodegenerative disease pathology in the murine model (2024) · cites this paper as Hanisch, 2002
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1
Berkenbosch, F., van Oers, J., del Rey, A., Tilders, F., & Besedovsky, H. (1987) · Science · doi:10.1126/science.2443979 · Cited by 1,151
“Inflammatory” Cytokines: Neuromodulators in Normal Brain?
Vitkovic, L., Bockaert, J., & Jacque, C. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.740457.x · Cited by 506
Banks, W. A., Ortiz, L., Plotkin, S. R., & Kastin, A. J. (1991) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20576-6 · Cited by 474 · cited 1×
“This may involve transportassisted BBB penetration of circulating IL-1, effects triggered at this border, true central IL-1 actions, and afferent fiber pathways stimulated by peripheral IL-1 (Banks et al., 1991; Banks and Kastin, 1997).”
BackgroundExpression of CX 3 CR1 chemokine receptors on neurons and their role in neuronal survival
Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090017497 · Cited by 385
Carlson, N. G., Wieggel, W. A., Chen, J., Bacchi, A., Rogers, S. W., & Gahring, L. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3963 · Cited by 301 · cited 2×
“Nevertheless, it is important to emphasize that too little cytokine signaling can be as deleterious as too much (Carlson et al., 1999; Mason et al., 2001).”
BackgroundRogers, J., & Lue, L.-F. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(01)00040-7 · Cited by 236
Yates, S. L., Burgess, L. H., Kocsis‐Angle, J., Antal, J. M., Dority, M. D., Embury, P. B., Piotrkowski, A. M., & Brunden, K. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741017.x · Cited by 202
Research works printed but not linked: 168
- 10.1016/S0167-5699(00)01652-2 · DOI
- 10.1016/S0952-7915(99)00051-5 · DOI
- 10.1111/j.1749-6632.1998.tb09548.x · DOI
- 10.1038/35094583 · DOI
- 10.4049/jimmunol.159.4.1604 · DOI
- 10.1002/glia.1106 · DOI
- 10.1016/S0306-4522(98)00032-3 · DOI
- 10.1038/nm1096-1074 · DOI
- 10.1016/S0306-4522(00)00516-9 · DOI
- 10.1016/S0166-2236(99)01453-8 · DOI
- 10.1016/S0955-0674(99)80034-9 · DOI
- 10.1006/exnr.1999.7345 · DOI
- 10.1002/(SICI)1098-1136(199609)18:1<11::AID-GLIA2>3.0.CO;2-6 · DOI
- 10.1523/JNEUROSCI.16-09-02945.1996 · DOI
- 10.1002/jemt.1121 · DOI
- 10.1016/S0165-5728(97)00103-3 · DOI
- 10.1038/379591a0 · DOI
- 10.1002/(SICI)1098-1136(20000215)29:4<293::AID-GLIA1>3.0.CO;2-A · DOI
- 10.1016/S0197-0186(01)00045-6 · DOI
- 10.1159/000125283 · DOI · Paper page
- 10.1210/edrv-17-1-64 · DOI · Paper page
- 10.1016/S0959-4388(00)00223-3 · DOI · Paper page
- 10.1038/89490 · DOI · Paper page
- 10.1002/glia.1047 · DOI
- 10.4049/jimmunol.165.1.397 · DOI · Paper page
- 10.1523/JNEUROSCI.13-10-04412.1993 · DOI
- 10.1016/S0165-0173(97)00038-6 · DOI
- 10.1038/12623 · DOI
- 10.1111/j.1469-7793.1999.0585p.x · DOI · Paper page
- 10.4049/jimmunol.151.3.1473 · DOI
- 10.1016/0896-6273(94)90159-7 · DOI
- 10.1523/JNEUROSCI.21-04-01179.2001 · DOI · Paper page
- 10.1074/jbc.272.4.2035 · DOI
- 10.1016/S0169-328X(99)00034-0 · DOI
- 10.1385/IR:21:2-3:159 · DOI
- 10.1038/35025229 · DOI
- 10.1038/sj.mp.4000389 · DOI
- Dinarello CA, 1997, Role of pro‐ and anti‐inflammatory cytokines during inflammation: experimental and clinical findings, J Biol Regul Homeost Agents, 11, 91
- Dinarello CA, 1997, Blocking interleukin‐1 and tumor necrosis factor in disease, Eur Cytokine Netw, 8, 294
- Dinarello CA, 1997, Induction of interleukin‐1 and interleukin‐1 receptor antagonist, Semin Oncol, 24, S9
- 10.3109/08830189809043005 · DOI
- Dinarello CA, 1998, The cytokine handbook, 35
- 10.1016/S0091-6749(99)70518-X · DOI
- 10.1016/S0306-4522(98)00407-2 · DOI
- 10.1007/978-0-585-37970-8_8 · DOI · Paper page
- 10.1016/0306-4522(93)90380-X · DOI
- 10.1523/JNEUROSCI.16-08-02508.1996 · DOI
- 10.1212/WNL.53.5.1104 · DOI
- 10.1016/S0304-3940(00)00977-0 · DOI
- 10.1084/jem.185.3.579 · DOI
- 10.1016/S0166-2236(00)01674-X · DOI
- 10.1172/JCI119488 · DOI
- 10.1016/0165-5728(94)90047-7 · DOI
- 10.1002/jemt.1120 · DOI
- 10.1016/S0166-2236(00)01617-9 · DOI
- 10.1523/JNEUROSCI.08-02-00709.1988 · DOI
- 10.1523/JNEUROSCI.08-07-02485.1988 · DOI
- 10.1002/glia.440070116 · DOI
- 10.1159/000112099 · DOI
- 10.1016/0197-0186(94)90066-3 · DOI
- Giulian D, 1995, Neuroglia, 671
- 10.3109/13550289909029740 · DOI
- 10.1523/JNEUROSCI.13-08-03368.1993 · DOI
- 10.1210/en.135.6.2465 · DOI
- 10.1016/0165-0173(95)00015-1 · DOI
- 10.1002/(SICI)1098-2396(199610)24:2<104::AID-SYN2>3.0.CO;2-J · DOI
- 10.1074/jbc.272.46.28853 · DOI
- 10.1016/S0306-4522(97)00040-7 · DOI
- Hanisch UK, 2001, Microglia in the degenerating and regenerating CNS, 79
- Hanisch UK, 2001, Psychoneuroimmunology, 585
- 10.1002/1521-4141(200107)31:7<2104::AID-IMMU2104>3.0.CO;2-3 · DOI
- 10.1073/pnas.95.18.10896 · DOI · Paper page
- 10.1016/S0079-6123(01)32114-3 · DOI
- 10.1002/glia.1101 · DOI
- 10.1046/j.1471-4159.2000.0750965.x · DOI
- 10.1126/science.290.5497.1768 · DOI · Paper page
- 10.1523/JNEUROSCI.21-06-01975.2001 · DOI · Paper page
- 10.1016/0166-2236(95)80029-2 · DOI
- 10.1016/0014-2999(90)90099-R · DOI
- 10.1016/S0165-5728(00)00239-3 · DOI
- 10.1006/clin.1997.4475 · DOI
- 10.1016/S0166-2236(00)02088-9 · DOI · Paper page
- 10.1016/0166-2236(96)10049-7 · DOI · Paper page
- 10.1074/jbc.275.14.10308 · DOI
- 10.4049/jimmunol.150.7.2659 · DOI
- 10.1523/JNEUROSCI.20-14-05292.2000 · DOI
- 10.1146/annurev.med.50.1.425 · DOI
- 10.1016/S0165-0173(97)00037-4 · DOI
- 10.1073/pnas.96.12.7047 · DOI · Paper page
- 10.1523/JNEUROSCI.19-11-04238.1999 · DOI
- 10.4049/jimmunol.163.3.1628 · DOI
- 10.1111/j.1749-6632.1998.tb09569.x · DOI
- 10.1016/S0165-5728(00)00295-2 · DOI
- 10.1523/JNEUROSCI.21-18-07046.2001 · DOI · Paper page
- 10.1159/000097327 · DOI
- 10.2174/1381612805666230111212056 · DOI
- 10.1016/S0197-4580(01)00289-5 · DOI
- 10.1016/S0197-4580(01)00307-4 · DOI · Paper page
- 10.1016/S0165-6147(99)01308-5 · DOI
- 10.1016/0166-2236(96)10047-3 · DOI
- 10.1046/j.1365-2990.1999.00200.x · DOI
- 10.1002/1096-9861(20010305)431:2<217::AID-CNE1066>3.0.CO;2-T · DOI
- 10.1038/35050116 · DOI
- 10.1046/j.1471-4159.2000.0751539.x · DOI
- 10.1093/jnen/59.6.471 · DOI
- 10.1002/jnr.1157 · DOI
- 10.1016/S0166-2236(00)02024-5 · DOI
- 10.1002/glia.1108 · DOI · Paper page
- 10.1002/1531-8249(200003)47:3<365::AID-ANA13>3.0.CO;2-G · DOI
- 10.1016/S0014-5793(98)00583-3 · DOI
- 10.1111/j.1469-445X.1999.01892.x · DOI
- 10.1016/S0962-8924(00)01856-0 · DOI
- 10.1038/378088a0 · DOI
- 10.1016/S1074-7613(00)00070-4 · DOI
- 10.1046/j.1471-4159.2000.0750576.x · DOI
- 10.1074/jbc.M008262200 · DOI
- 10.1016/S0197-4580(01)00291-3 · DOI
- 10.1002/(SICI)1097-4547(19990515)56:4<441::AID-JNR11>3.0.CO;2-G · DOI
- 10.1038/nm1201-1356 · DOI · Paper page
- 10.1016/S0169-328X(98)00284-8 · DOI
- 10.1046/j.1471-4159.1999.0722215.x · DOI
- 10.1097/00005072-199910000-00006 · DOI
- 10.1016/S0006-8993(01)02174-6 · DOI
- 10.2302/kjm.45.239 · DOI
- 10.1016/S0165-0173(99)00007-7 · DOI
- 10.1007/978-3-7091-6391-7_4 · DOI
- 10.1016/S0169-328X(99)00016-9 · DOI
- 10.1146/annurev.immunol.18.1.217 · DOI · Paper page
- 10.1016/0166-2236(95)93890-A · DOI
- 10.1038/nm0796-746 · DOI
- 10.1038/sj.mp.4000223 · DOI
- 10.1172/JCI119808 · DOI
- 10.1016/S0166-2236(00)01661-1 · DOI
- 10.4049/jimmunol.164.9.4893 · DOI
- 10.1046/j.1471-4159.1999.721466.x · DOI
- 10.1073/pnas.95.13.7778 · DOI · Paper page
- 10.1111/j.1749-6632.2000.tb06346.x · DOI
- 10.1016/S0079-6123(08)64017-0 · DOI
- 10.1038/sj.bjp.0701002 · DOI
- 10.1074/jbc.275.2.1169 · DOI
- 10.1002/(SICI)1097-4547(19981001)54:1<68::AID-JNR8>3.0.CO;2-F · DOI
- 10.1016/S0165-5728(99)00218-0 · DOI · Paper page
- 10.4049/jimmunol.159.3.1344 · DOI
- 10.1002/(SICI)1098-1136(20000215)29:4<355::AID-GLIA6>3.0.CO;2-4 · DOI
- 10.1016/S0301-0082(98)00083-5 · DOI
- Stoll G, 2000, Cytokines in CNS disorders: neurotoxicity versus neuroprotection, J Neural Transm, 59, 81
- 10.1016/S0301-0082(98)00069-0 · DOI · Paper page
- 10.1002/1097-4547(20000701)61:1<10::AID-JNR2>3.0.CO;2-E · DOI
- 10.1016/0165-5728(94)90031-0 · DOI
- 10.1016/S0006-8993(97)01166-9 · DOI
- 10.1016/S0165-5728(00)00404-5 · DOI
- 10.1152/ajpregu.1999.276.4.R1132 · DOI
- 10.1126/science.286.5448.2352 · DOI
- 10.1002/1521-4141(200111)31:11<3228::AID-IMMU3228>3.0.CO;2-7 · DOI
- 10.1016/S0165-0173(99)00024-7 · DOI
- 10.4049/jimmunol.164.5.2759 · DOI
- 10.1016/S0378-4274(98)00318-X · DOI
- Vilcek J, 1998, The cytokine handbook, 1
- Ware CF, 1998, The cytokine handbook, 549
- 10.1016/S0165-5728(98)00248-3 · DOI
- 10.1016/S0169-328X(00)00069-3 · DOI
- 10.4049/jimmunol.161.11.6368 · DOI
- 10.1016/S1074-7613(00)00023-6 · DOI
- 10.1038/87945 · DOI · Paper page
- 10.1177/135245850000600103 · DOI
- Zhang M, 1998, The cytokine handbook, 517
- 10.1016/0960-5428(96)00017-4 · DOI
- 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V · DOI
Cited by
Sorted by citations
Items 901–988 of 988
Recent developments in delirium after oral and maxillofacial free-flap reconstruction.
Zhang, R., Zhang, W., Ren, Y.-M., Yu, J.-Y., Li, L., & Zhang, Y.-K. (2024) · Journal of Stomatology Oral and Maxillofacial Surgery · doi:10.1016/j.jormas.2024.102045 · Cited by 3
Chamera, K., Curzytek, K., Kamińska, K., Leśkiewicz, M., & Basta‐Kaim, A. (2024) · Life · doi:10.3390/life14060721 · Cited by 4
Togre, N. S., Melaka, N., Bhoj, P., Mogadala, N., Winfield, M., Trivedi, J., Grove, D., Kotnala, S., Rom, S., Sriram, U., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4350949/v1 · Cited by 3
“IFN-γ acts as potent inducer of TNF-α during neuroin�ammation [55, 56].”
BackgroundMa, C., Huang, T., Yu, J. S., Lý, T. L., Huynh, K. L. V., Kwon, S. W., Park, J., & Yang, H. (2024) · RSC Advances · doi:10.1039/d3ra08686k · Cited by 3
Evaluation of the brain cellular damage during liver transplantations
Deniz, M., Sezer, E., Tetik, A., & Ulukaya, S. (2023) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_332_22 · Cited by 3
TOMITA, N., Nakamura, T., Sunden, Y., Miyata, H., & MORITA, T. (2020) · Neuropathology · doi:10.1111/neup.12643 · Cited by 3
“Increased TNFα could be harmful to neurons when it enhances edema or inflammation to an excessive degree.(15,21) Therefore, the high expression of TNFα, edema, and the activation of microglia recognized as morphological changes to a rod-like, hypertrophic, or ameboid shapes may aggravate neuronal damage and death in r…”
BackgroundInflammation and immune-mediated neurobehavioral alterations : a critical role for microglia
Lacabanne, C. (2018) · theses.fr (ABES) · doi:10.70675/41a4e2a3zdbb7z4aa0z899dz9553bb07954b · Cited by 1
Necroptosis and microglia activation after chronic ischemic brain injury in mice
Zhang, S., Wang, Y., Xie, H., Yu, Q. B., Wu, J., Wu, Y., & Zhu, Y. (2017) · European Journal of Inflammation · doi:10.1177/1721727x17706855 · Cited by 5
Li, X., Wu, Z., Yao, C. H., Zhang, P., Zhu, Q., Nan, S., Xiao, L., & Qi, S. (2026) · Research · doi:10.34133/research.1163 · Cited by 3
“Early research established that glial activation, along with the generation of pro-inflammatory cytokines (e.g., IL-1 β , IL-6, and TNF-α ) and ROS, collectively contributes to neuronal dysfunction and death [ 33 – 35 ].”
Kim, D. H., Moon, H. Y., & Lee, M. C. (2026) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.70090 · Cited by 2
“Produced primarily by activated glial cells, including microglia and astrocytes, these cytokines initiate and amplify inflammatory cascades within the CNS (Hanisch 2002; Rizzo et al. 2018).”
InfluentialHuang, S., Zhou, Y., Liu, J., Sun, S., Zhang, T., Ma, L., Liu, S., Deng, D., Shu, S., Wang, Y., et al. (2025) · Perioperative Medicine · doi:10.1186/s13741-025-00565-1 · Cited by 2
Berkiks, I., Aziz, N. M. A., Moses, B., Brombacher, T. M., & Brombacher, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1453742 · Cited by 2
Jana, M., Mondal, S., Jana, A., & Pahan, K. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156457 · Cited by 5
Ohgidani, M., Kushima, I., Inamine, S., Kyuragi, S., Sagata, N., Nakao, T., Kanba, S., Ozaki, N., & Kato, T. A. (2022) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13505 · Cited by 3
Kleidonas, D., Kirsch, M., Andrieux, G., Pfeifer, D., Boerries, M., & Vlachos, A. (2022) · bioRxiv · doi:10.1101/2022.04.14.487444 · Cited by 2
“This 448 observation attracted considerable interest, particularly after the discovery that TNFα was 449 expressed in the CNS under physiological conditions [7] and the identification of microglia as 450 a major source of TNFα in the brain [9].”
BackgroundSeney, M. L., Moon-Kim, S., Glausier, J., Hildebrand, M. A., Xue, X., Zong, W., Wang, J.-B., Shelton, M. A., Phan, B. N., Srinivasan, C., et al. (2020) · bioRxiv · doi:10.1101/2020.09.14.296707 · Cited by 2
“Third, the cytokines we have discussed above, including IL-1β, IL-6, IL-2, and 421 TNFα, are all secreted by activated microglia(150).”
BackgroundSchweig, J. E., Yao, H., Jin, C., Crawford, F., MULLAN, M. J., & Paris, D. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134992 · Cited by 2
Kashefi, B., Mohammadi, M., Rezaei, F., Ghadami, N., Jalili, K., & Jalili, A. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s234013 · Cited by 2
Computational Modelling of TNFα Pathway in Parkinson’s Disease – A Systemic Perspective
Sasidharakurup, H., Nair, L., Bhaskar, K. S. A., & Diwakar, S. (2019) · Studies in computational intelligence · doi:10.1007/978-3-030-36683-4_61 · Cited by 2
Tokgoz, S. (2019) · Austin Journal of Cerebrovascular Disease & Stroke · doi:10.26420/austinjcerebrovascdisstroke.2019.1080 · Cited by 2
Hassani, M., Sabouni, F., Emamgholipour, S., Rafiee, M. H., Fallah, M., Abbasi, S., & Ansari, M. (2016) · doi:10.22037/amls.v2i2.14529 · Cited by 2
Screening of Key Genes Associated with Ischemic Stroke via Microarray Data
Wang, J.-M., Zhou, D., Qin, H., Xu, Y., Guan, Y., & Zang, W. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100016036 · Cited by 2
Kuang, X.-Y., Lin, W.-J., Wang, D.-L., Qi, X.-L., Pan, Y.-Q., Sun, H., & Xie, X. (2012) · Acta Psychologica Sinica · doi:10.3724/sp.j.1041.2011.00283 · Cited by 2
Mechanisms of neurotoxicity of fluoride or aluminum: implications for neurodegenerative disease risk
Wang, Z.-L., Baker, T. R., & Malin, A. J. (2026) · Current Research in Toxicology · doi:10.1016/j.crtox.2026.100313 · Cited by 1
“…homeostasis by forming the cytoskeleton, regulating neuronal survival and differentiation, myelinating axons for rapid signal conduction, and balancing ion and neurotransmitter levels and may be disrupted by environmental toxicants such as fluoride (Dec et al., 2017; Jessen, 2004; Hanisch, 2002).”
Xl, W., Liu, Y., Li, M., Xu, H., Ju, Y., Cui, L., Liu, L., & Yang, F. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124475 · Cited by 2
Chen, X., Zhang, X., Jin, F., & Zhang, C. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106527 · Cited by 1
iPSC-derived microglia: Decoding roles and therapeutic opportunities in neurodegenerative diseases
Shan, D., Wang, H., Li, J., Tang, Y., Zhan, Z., Yan, C., Xu, J., & Liu, F. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.111779 · Cited by 1
Park, H., Park, J.-E., Freeman, B. H., Yang, B. S. K., Ting, S., Suh, A. K., Savarraj, J. P. J., Huang, S., Körbelin, J., Choi, H. A., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.195638 · Cited by 2
“Genome-wide RNA sequencing (RNA-seq) or gene expression profiling of human bAVM tissues/blood revealed the presence of inflammatory cytokines and chemokines (20–23), which were confined primarily to microglia (MG) and macrophages (M ϕ ) (together, MG/M ϕ ) (24, 25).”
He, S., Liu, L., Wang, X.-Q., Wang, H., Fu, X., Kong, L., Wang, S., Wang, P.-K., Cai, X., & Wang, Y. (2025) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2025.578826 · Cited by 1
Time-restricted feeding in adult mice improves mood-related behaviors in a sex-dependent manner
Bell, K. S., Darling, J. S., Prabhakar, A., Imad, S. T., Gaudet, A. D., & Fonken, L. K. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115867 · Cited by 7
Kim, S., Burrous, H., Harmon, E., Vance, L., Wu, T., Andersohn, A. P., Doan, A. N., Wolocko, D., Wise, Z., Kitamura, Y., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-7383703/v1 · Cited by 1
Siquier-Dameto, G., Beltrán, J. G., Bellia, G., Boadas‐Vaello, P., & Verdú, E. (2025) · Physiologia · doi:10.3390/physiologia5030032 · Cited by 1
Revi, N., Nandeshwar, M., Harijan, D., Sankaranarayanan, S. A., Joshi, M., Prabusankar, G., & Rengan, A. K. (2025) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00791 · Cited by 2
Mitsuhashi, M., Hirata, A., Oguma, Y., Ishida, H., & Kawata, K. (2024) · Research Square · doi:10.21203/rs.3.rs-3997676/v1 · Cited by 1
Han, J.-Y., Park, M., & Lee, H. (2023) · Molecular & Cellular Toxicology · doi:10.1007/s13273-023-00399-2 · Cited by 1
“During inflammation, microglia cells promote the secretion of various cytokines to repair damaged tissues and restore homeostasis (Woodroofe 1995; Hanisch 2002).”
Innate and adaptive glial cell responses in Alzheimer’s disease
Singh, A., & Singh, T. R. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00039 · Cited by 1
Сергеевна, П. А. (2023) · Rheumatology Science and Practice · doi:10.47360/1995-4484-2023-77-86 · Cited by 1
Toxic leukoencephalopathy caused by chemotherapeutic drugs other than methotrexate
Park, S.-H., Lim, K.-Y., Kim, S.-I., Kim, H., Kang, J., Park, J. W., Won, J., & Shin, D.-Y. (2021) · doi:10.21203/rs.3.rs-36667/v1 · Cited by 1
Chronic Intermittent Ethanol Activates CHOP in Striatal Microglia and Exacerbates Ethanol WithdrawalPreprint
Williams, R. G., Dufour, B. D., Coffey, K. R., Lesiak, A. J., Nickelson, W. B., Dawkins, A. J., Garden, G. A., & Neumaier, J. F. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.02.280156
Inflammatory cytokine levels in multiple system atrophy
Wang, H., Wang, W., Yi, Z., Zhao, P., Zhang, H., & Pan, P. (2020) · Medicine · doi:10.1097/md.0000000000021509 · Cited by 1
Liu, X., Hu, B., Wang, F., Song, Y.-H., Fan, Z., Wei, H., Qiu, R., & Xu, W. (2016) · Developmental and Comparative Immunology · doi:10.1016/j.dci.2016.07.017 · Cited by 1
Development of Stable Long‐term Electrode Tissue Interfaces for Recording and Stimulation
Schouenborg, J. (2016) · Wiley eBooks · doi:10.1002/9781118816028.ch2
Ernawati, T., Suhendro, G., Sudiana, I., Putra, S., Jm, H., Sunarjo, Turchan, A., & Rantam, F. (2016) · doi:10.4236/jbise.2016.94018 · Cited by 1
Inflammatory Mediators and the Blood-Brain Barrier
Dorovini‐Zis, K., & Easton, A. (2015) · CRC Press eBooks · doi:10.1201/b18606-10 · Cited by 1
The Blood-Brain Barrier and the Immune Privilege of the Central Nervous System
Clarkson, B. D. S., Harris, M. G., Rayasam, A., & Fábry, Z. (2015) · CRC Press eBooks · doi:10.1201/b18606-9 · Cited by 1
Hanamsagar, R., Cardona, S. M., Kielian, T., & Cardona, A. E. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_5
Hussain, I., & Gutmann, D. (2011) · Expert Review of Ophthalmology · doi:10.1586/eop.11.31 · Cited by 1
Carli, A. D., Filipponi, C., Polini, B., Sancho‐Bornez, V., Basso, E., Filippini, F., Dardano, A., Sardelli, F., Daniele, S., Contestabile, M., et al. (2026) · Journal of Translational Medicine · doi:10.64898/2026.01.29.702298
“To profile microglial activation state, qPCR assessed MHC II and MCP1 (pro-inflammatory/M1-like markers) [13, 42] and ARG1 (M2-like marker) [14].”
Chen, W.-W., Zhang, Y.-J., Zhou, X.-R., Yan, J.-N., Song, Y.-M., Shen, J.-B., & Gu, X.-S. (2026) · iScience · doi:10.1016/j.isci.2026.117833
Delshad, S., Jafarinejad-Farsangi, S., Ghasem-Shirazi, M., Kheirandish, R., & Bashiri, H. (2026) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/s00210-026-05705-y
“…imbalance in pro-and anti-inflammatory cytokines, particularly an increased interleukin-1β/interleukin-10 (IL-1β/ IL-10) ratio, is associated with enhanced neuroinflammation, glial activation, and tumor progression (Hambardzumyan et al. 2016; Hanisch 2002; Mantovani et al. 2017; Zhu et al. 2012).”
Wang, X.-H., Xie, B., Yuan, X., Rong, J., Lv, X., Ma, Q., Shen, L., & Han, B. (2026) · Metabolic brain disease · doi:10.1007/s11011-026-01934-5
“Microglia are the principal cellular source of these cytokines under hypoxic stress (Hanisch 2002).”
Microglial CHOP expression contributes to the consequences of ethanol withdrawal
Williams, R. G., Dufour, B. D., Coffey, K. R., Lesiak, A. J., Nickelson, W. B., Dawkins, A. J., Garden, G. A., & Neumaier, J. F. (2026) · Addiction Neuroscience · doi:10.1016/j.addicn.2026.100269
Piotrowska, A., Starnowska-Sokół, J., Ciapała, K., Barut, J., Pawlik, K., Ciechanowska, A., Kwiatkowski, K., Kreiner, G., & Mika, J. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01761-3
GPCR-mediated regulation of glial TNF productionPreprint
Abbasi, Z., Sadighparvar, S., Franquin, M., & Stellwagen, D. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.12.731854
“Microglia are another crucial type of glial cell in the brain, can produce substantial amounts of TNF and play a significant role in neuroinflammation and neurodegenerative diseases (Hanisch, 2002; Smith et al., 2012).”
Langness, V. F., Simmons, D. A., Kaur, S., Massa, S. M., & Longo, F. M. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08276-x
“Neuroin-flammation also involves release of cytokines, which are elevated in the brains and plasma of patients and mouse models of neurodegenerative diseases [159, 165].”
Gardner-Stephen, K., Carvajal-Quisilema, R. J., Andrianova, L., McGonigal, R., Sharma, D., Barrie, J. A., Saathoff, M., Cole, J., Jamieson, N. B., Craig, M. T., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-51581-0 · Cited by 1
Neuroinflammation in epilepsy: Mitochondrial connections and therapeutic targets
Olkhova, E. A., Dimitriou, A., Johnson, B. M., Hanaford, A., & Johnson, S. C. (2026) · Brain Mechanisms · doi:10.1016/j.bramec.2026.202535
Sahebdel, F., Zia, A., Quintá, H. R., Stucky, A., Morse, L. R., Olson, J. K., & Battaglino, R. A. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1783899
“Microglia, the CNS’s resident immune cells, initiate extensive inflammatory cascades in response to damage signals in combination with autocrine and paracrine signaling from astrocytes and neurons (Hanisch, 2002).”
Hammond, E. R., Monari, P. K., Luebke, E. M., Johnson, A. K., Auger, A. P., & Marler, C. A. (2025) · bioRxiv · doi:10.1101/2025.11.23.690017
The role of circulating free nucleic acids on Alzheimer's Disease
Menegaz, L. L., Cohen, D., Sommer, L. T., Santos, H. L. S., Pinto, F. C., Marrone, L. C. P., Schaun, M. I., & Dias, C. T. (2025) · Research, Society and Development · doi:10.33448/rsd-v14i11.49915
“Hanisch (2002) demonstrates in his study, based on in vivo and in vitro experiments, that microglia are capable of synthesizing a significant amount of these substances in response to immune stress, further supporting the possibility that microglia are a primary and independent source of signaling.”
González, J. I. G., Gálvez‐Contreras, A. Y., Jimenez-Navarro, I., Perez-Alcaraz, I., González-Pérez, Ó., & González-Castañeda, R. E. (2025) · Healthcare · doi:10.3390/healthcare13121462
“In clinical studies females with a history of amphetamine addiction, increased ACTH levels, potentially driven by estrogenic modulation, coincide with elevated IL-6 levels and corresponding impairments in cognitive flexibility [26,27].”
Studies on Anti-inflammatory Effects of Gyejigamcho-tang Extracts
Kim, T. Y., & Jo, N. (2025) · Journal of Physiology & Pathology in Korean Medicine · doi:10.15188/kjopp.2025.04.39.2.47
Glial cells in neurodegenerative diseases: a review
Pranto, A. H., Khandker, S. S., Uddin, M. E., Aktar, S., Mumu, S. I., Khan, R. I., Chowdhury, N. K., Prekbunjun, J., Zisan, A., & Begum, R. (2025) · Neurophysiology · doi:10.1007/s11062-026-10018-0
Rat primary cortical cell tri-culture to study effects of amyloid-beta on microglia functionPreprint
Kim, H., Le, B., Goshi, N., Zhu, K., Grodzki, A. C., Lein, P. J., Zhao, M., & Şeker, E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.15.584736
“It is well-established that microglia secrete various cytokines upon exposure to external stimuli, including A β proteins, in both in vitro and in vivo studies reported by others (Hanisch, 2002; Shaftel et al., 2008; Wang et al., 2015; Decourt et al., 2017; Perez-Nievas et al., 2021).”
BackgroundMagnani, L., Fusar‐Poli, L., Parise, A., Nguyen, K. D., Saverino, D., & Costanza, A. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111158
Retinal affectation in Huntington’s disease mouse models concurs with a local innate immune responsePreprint
Arroba, A. I., Gallardo-Orihuela, A., Cano-Cano, F., Martín-Loro, F., González-Montelongo, M. D. C., Hervás-Corpión, I., de la Villa, P., Ramón-Marco, L., Gómez-Jaramillo, L., & Valor, L. M. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.17.523578
Cardiorespiratory alterations in a newborn ovine model of systemic viral inflammation
Nault, S., Tremblay, S., Imane, R., Omar, S. A., Nadeau, C., Samson, N., Creuze, V., Carrault, G., Pladys, P., & Praud, J. (2022) · Pediatric Research · doi:10.1038/s41390-022-01958-4
Ghosh, A., Ghosh, P., Deb, I., & Bandyopadhyay, S. K. (2021) · Brain and Behavior · doi:10.1002/brb3.2315 · Cited by 2
“To operate with such sensitivity, they express large number of receptors and act as a source or sink of a plethora of soluble factors, cytokines, and chemokines (Hanisch, 2002).”
BackgroundAcyloxyacyl Hydrolase Regulates Microglia-Mediated Pelvic Pain Through Toll-Like Receptor-4Preprint
Rahman-Enyart, A., Yaggie, R., Yang, W., Bollinger, J., Winter, D., Schaeffer, A., & Klumpp, D. (2021) · bioRxiv · doi:10.1101/2021.02.26.433087
“Activated microglia are a source of cytokine release which can drive immune responses and other neuromodulatory functions [23].”
BackgroundLara-Espinosa, J. V., Marquina‐Castillo, B., Santana-Martínez, R. A., Zetter, M. A., Maldonado, P. D., Becerril‐Villanueva, E., Pérez‐Sánchez, G., Pavón, L., Mata‐Espinosa, D., Barrios‐Payán, J., et al. (2020) · doi:10.21203/rs.3.rs-24798/v1 · Cited by 11
“The high production of peripheral inflammatory cytokines or activated immune cells, as well as the vagus afferent nerve stimulation, can modify the tone of neuronal networks and induce neuroinflammation by inducing resident production of cytokines [40].”
BackgroundContext dependent cytokine secretion by stem cell derived microglia in vitro
Vandekolk, T. H. (2020) · doi:10.26180/5e6b44c2c336c
“This is extremely interesting, as it contradicts the work performed in Chapter Four, and supports the use of LPS for microglial stimulation (327, 432, 433, 623).”
ResultBai, D., Ma, Y., Lv, L., Wang, Y., Yang, W., & Ma, Y. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.134755
RetractedAdvances in the understanding of cellular pathogenesis associated with Autism Spectrum Disorder
Savory, K., & Syed, Y. A. (2019) · Journal for ReAttach Therapy and Developmental Diversities · doi:10.26407/2019jrtdd.1.21
“Microglia are the immune cells of the brain and are capable of producing and reacting to a range of immune responses by secreting cytokines (Hanisch, 2002).”
BackgroundMoshkforoush, A., Balachandar, L., Moncion, C., Santana, J., & Diaz, J. R. (2019) · bioRxiv · doi:10.1101/549469
Lee, S.-G., & Kang, H. (2018) · Biomedical Science Letters · doi:10.15616/bsl.2018.24.4.398
“인간의 iNOS는 염증성질환이 있 는 환자의 macrophage에서 다량의 NO를 생성하여 세균침 입을 억제하거나 혹은 T-세포증식을 억제하여 국소 염증 반응을 하향시키는 방어에 중요한 역할을 하고 있는 것 으로 보고되고 있다(Wang et al., 2002; Hanisch, 2002).”
Galstyan, A., Chiechi, A., Korman, A., Sun, T., Israel, L., Braubach, O., Patil, R., Shatalova, E., Ljubimov, V., Markman, J., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/466508
Neuro-inflammation and its effects on cognition: A review of literature
Purnichi, T., Roşca, A., Giurgiuca, A., Pavel, A. N., & Matei, V. P. (2018) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2018.3.2
Silva, R. X. D. C., Rocha, S. P., Souza, D. P. D. S., Lima, M. G., & Maximino, C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/326017 · Cited by 1
“This last observation ties well with the observation of enrichment in immune and inflammatory pathways, given the role of microglia in these functions in the brain (Hanisch, 2002).”
ResultNguyen, A. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3057d35z · Cited by 1
Characterisation of novel therapies to mitigate inflammation in retinal degenerations
Saxena, K. (2015) · ANU Open Research (Australian National University) · doi:10.25911/5d78d614a6941
“α, interleukin (IL)-1β [60, 75, 76], and release of nitric oxide [71, 77].”
BackgroundActivation of microglia in the nucleus of the solitary tract by inferior alveolar nerve injury
Kakihara, R., Suwabe, T., Nishikawa, Y., & Morita, S. (2015) · doi:10.18905/jodu.49.1_21
Microglial involvement in brain physiopathology: in vitro studies using rat primary cultures
Mengoni, I. (2014) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/6466
“Now it is well known that these cells are capable of integrating ad responding appropriately to different inputs (Hanisch, 2002; Schwartz et al., 2006; Hanisch and Kettenmann, 2007) and microglial activation is a process more diverse and dynamic than has been considered in the past.”
Implication des neurones exprimant NUCB2/nesfatine-1 dans la régulation de l'homéostasie énergétique
Bonnet, M. S. (2013) · theses.fr (ABES) · doi:10.70675/82840557z70b7z4214zbe5azca1e4f81d53a
“Elles sont également produites au niveau du système nerveux central, majoritairement par les 54 cellules microgliales et les astrocytes (Dong et Benveniste, 2001; Hanisch, 2002).”
BackgroundJuan, A. D. (2013) · InTech eBooks · doi:10.5772/54306
“In a healthy brain, microglia exhibit a resting surveillance state associated with active explo‐ ration of their environment for exogenous or endogenous signals representing a threat to the homeostasis [1-5].”
BackgroundGap Junctions in Antigen-Presenting Cells
Sáez, P. J., Shoji, K. F., & Sáez, J. C. (2013) · CRC Press eBooks · doi:10.1201/b14166-6
Targeting Microglia to Prevent Post-Traumatic Epilepsy
Barth, D. S. (2012) · doi:10.21236/ada590837
Inflammation in Parkinson’s Disease: Causes and Consequences
Louise, M., Toulouse, A., & Yvonne, M. (2012) · InTech eBooks · doi:10.5772/18184
“In the brain, it has been reported that cytokines function in growth promotion, inhibition and proliferation of astrocytes and oligodendrocytes (Hanisch, 2002), modulation of neurotransmitter release (Zalcman et al., 1994) long-term potentiation (Nolan et al., 2005) behavioural impairments such as…”
Metadata
- Authors
- Hanisch, U.
- Affiliations
- Max Delbrück Center (DE)
- Corresponding author
- Hanisch, Uwe‐Karsten
- Venue
- Glia
- Publisher
- Wiley
- Published
- 2002-10-04
- Volume
- 40
- Issue
- 2
- Pages
- 140-155
- ISSN
- 0894-1491 (ISSN-L)
- 1098-1136
- OpenAlex
- W2090804892
- Cited by
- 1,645
- References
- 0
- Citations by year
- 2026: 29 · 2025: 39 · 2024: 62 · 2023: 59 · 2022: 68 · 2021: 85 · 2020: 82 · 2019: 76 · 2018: 85 · 2017: 79 · 2016: 70 · 2015: 81 · 2014: 86 · 2013: 94 · 2012: 93
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Glia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Keywords
- microglia, cytokines, chemokines, microglial activation, neuroinflammation, neuroprotection, astrocyte-microglia interaction, tissue repair, neurotoxicity, neuropathology, innate immunity
- MeSH terms
- Animals, Cell Communication, Endocrine System, Endothelium, Vascular, Humans, Neuroglia, Neurons, Cytokines, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review